Home/CellTrans/José Oberholzer, MD

JO

José Oberholzer, MD

Founder, President & Chief Medical Officer

Therapeutic Areas

Type 1 Diabetes

CellTrans Pipeline

Drug	Indication	Phase
LANTIDRA (donislecel-jujn)	Type 1 Diabetes with severe hypoglycemia	Approved

Leadership Team at CellTrans

James McGarrigle, PhD

Chief Operating Officer

Giovanna La Monica, PhD

Chief Quality Officer

Peter Rios, PhD

Chief Scientific Officer

View full CellTrans profile